Department of Gynecology and Obstetrics, Emory University, Glenn Building 4th Floor, Atlanta, GA 30303, USA; Gynecology Comprehensive Breast Center, Winship Cancer Institute at Grady Memorial Hospital; Avon Breast Center.
Obstet Gynecol Clin North Am. 2022 Mar;49(1):87-116. doi: 10.1016/j.ogc.2021.11.009.
Breast cancer is the most commonly diagnosed nonskin cancer in women. To decrease the breast cancer burden, conserve resources, and decrease unnecessary treatments, guidelines suggest interventions be reserved for those women at greatest risk for disease. Risk assessment incorporating breast cancer risk factors and risk assessment models is of paramount importance in identifying women who have the greatest benefit from risk reduction strategies. Principles of shared decision-making should guide practitioners to incorporate patients' values, goals, and objectives in decisions around genetic testing, pharmacologic intervention, enhanced surveillance, and other risk reduction strategies.
乳腺癌是女性最常见的非皮肤癌。为了降低乳腺癌负担、节约资源并减少不必要的治疗，指南建议将干预措施保留给那些患有疾病风险最高的女性。结合乳腺癌危险因素和风险评估模型的风险评估在确定从降低风险策略中获益最大的女性方面至关重要。共享决策原则应指导从业者将患者的价值观、目标和期望纳入有关基因检测、药物干预、强化监测和其他降低风险策略的决策中。
